Literature DB >> 29949087

Radiologic Cerebral Reperfusion at 24 h Predicts Good Clinical Outcome.

Federico Carbone1, Giorgio Busto2, Marina Padroni3, Andrea Bernardoni4, Stefano Colagrande2, Franco Dallegri5,6, Fabrizio Montecucco5,6,7, Enrico Fainardi8.   

Abstract

Cerebral reperfusion and arterial recanalization are radiological features of the effectiveness of thrombolysis in acute ischemic stroke (AIS) patients. Here, an investigation of the prognostic role of early recanalization/reperfusion on clinical outcome was performed. In AIS patients (n = 55), baseline computerized tomography (CT) was performed ≤ 8 h from symptom onset, whereas CT determination of reperfusion/recanalization was assessed at 24 h. Multiple linear and logistic regression models were used to correlate reperfusion/recanalization with radiological (i.e., hemorrhagic transformation, ischemic core, and penumbra volumes) and clinical outcomes (assessed as National Institutes of Health Stroke Scale [NIHSS] reduction ≥ 8 points or a NIHSS ≤ 1 at 24 h and as modified Rankin Scale [mRS] < 2 at 90 days). At 24 h, patients achieving radiological reperfusion were n = 24, while the non-reperfused were n = 31. Among non-reperfused, n = 15 patients were recanalized. Radiological reperfusion vs. recanalization was also confirmed by early increased levels of circulating inflammatory biomarkers (i.e., serum osteopontin). In multivariate analysis, ischemic lesion volume reduction was associated with both recanalization (β = 0.265; p = 0.014) and reperfusion (β = 0.461; p < 0.001), but only reperfusion was independently associated with final infarct volume (β = - 0.333; p = 0.007). Only radiological reperfusion at 24 h predicted good clinical response at day 1 (adjusted OR 16.054 [1.423-181.158]; p = 0.025) and 90-day good functional outcome (adjusted OR 25.801 [1.483-448.840]; p = 0.026). At ROC curve analysis the AUC of reperfusion was 0.777 (p < 0.001) for the good clinical response at 24 h and 0.792 (p < 0.001) for 90-day clinical outcome. Twenty-four-hour radiological reperfusion assessed by CT is associated with good clinical response on day 1 and good functional outcome on day 90 in patients with ischemic stroke.

Entities:  

Keywords:  Inflammation; Ischemic core; Ischemic stroke; Penumbra; Recanalization; Reperfusion

Mesh:

Substances:

Year:  2018        PMID: 29949087     DOI: 10.1007/s12975-018-0637-8

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  7 in total

Review 1.  Clinical Imaging of the Penumbra in Ischemic Stroke: From the Concept to the Era of Mechanical Thrombectomy.

Authors:  Lucie Chalet; Timothé Boutelier; Thomas Christen; Dorian Raguenes; Justine Debatisse; Omer Faruk Eker; Guillaume Becker; Norbert Nighoghossian; Tae-Hee Cho; Emmanuelle Canet-Soulas; Laura Mechtouff
Journal:  Front Cardiovasc Med       Date:  2022-03-09

2.  Clinical Significance and Influencing Factors of Microvascular Tissue Reperfusion After Macrovascular Recanalization.

Authors:  Xuesong Bai; Fan Yu; Qiuyue Tian; Wei Li; Araman Sha; Wenbo Cao; Yao Feng; Bin Yang; Yanfei Chen; Peng Gao; Yabing Wang; Jian Chen; Adam A Dmytriw; Robert W Regenhardt; Renjie Yang; Zhaolin Fu; Qingfeng Ma; Jie Lu; Liqun Jiao
Journal:  Transl Stroke Res       Date:  2022-06-27       Impact factor: 6.800

3.  Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer.

Authors:  Federico Carbone; Francesco Grossi; Aldo Bonaventura; Alessandra Vecchié; Silvia Minetti; Nicholas Bardi; Edoardo Elia; Anna Maria Ansaldo; Daniele Ferrara; Erika Rijavec; Maria Giovanna Dal Bello; Federica Biello; Giovanni Rossi; Marco Tagliamento; Angela Alama; Simona Coco; Paolo Spallarossa; Franco Dallegri; Carlo Genova; Fabrizio Montecucco
Journal:  Clin Exp Metastasis       Date:  2019-08-02       Impact factor: 5.150

4.  Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE Study.

Authors:  Federico Carbone; Jennifer Meessen; Marco Magnoni; Daniele Andreini; Aldo Pietro Maggioni; Roberto Latini; Fabrizio Montecucco
Journal:  Cells       Date:  2022-02-15       Impact factor: 6.600

5.  Post-ASPECTS based on hyperdensity in NCCT immediately after thrombectomy is an ultra-early predictor of hemorrhagic transformation and prognosis.

Authors:  Lulu Chen; Ziqi Xu; Chen Zhang; Yachen Ji; Xianjun Huang; Weimin Yang; Zhiming Zhou; Shuiping Wang; Kai Wang; Benyan Luo; Jingye Wang
Journal:  Front Neurol       Date:  2022-08-10       Impact factor: 4.086

Review 6.  Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy.

Authors:  Yinghua Jiang; Ning Liu; Jinrui Han; Yadan Li; Pierce Spencer; Samuel J Vodovoz; Ming-Ming Ning; Gregory Bix; Prasad V G Katakam; Aaron S Dumont; Xiaoying Wang
Journal:  Transl Stroke Res       Date:  2020-11-02       Impact factor: 6.829

Review 7.  Osteopontin as a candidate of therapeutic application for the acute brain injury.

Authors:  Yunxiang Zhou; Yihan Yao; Lesang Sheng; Jianmin Zhang; John H Zhang; Anwen Shao
Journal:  J Cell Mol Med       Date:  2020-07-13       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.